Alexander KarpAlexander Karp earned $1B in 2024

In 2023, Patrick J. McEnany earned $1.00M in total compensation at Catalyst Pharmaceutical, including $500.00K salary, $150.00K bonus and $300.00K in stock. Currently holds stock worth $319.82M. Has donated $1.18M in stock to charitable causes. Led Catalyst Pharmaceutical as CEO for 9 years.

Compensation History

Annual executive compensation data for Patrick J. McEnany, including salary, bonuses, and stock awards.

Year

2023

Total Compensation

$1.00M

Salary

$500.00K

Bonus

$150.00K

Other

$50.00K

Salary

$500.00K

Board Justification

The compensation philosophy aligns with company performance and peer benchmarking to ensure competitive pay while retaining key talent.

Bonus

$150.00K

Board Justification

The bonus is based on the achievement of specific performance metrics set by the board, including revenue growth and operational efficiency, paid out in cash in 2023.

Other Compensation

$50.00K

Board Justification

Other compensation includes health benefits and retirement contributions paid in 2023.

Restricted Stock

$300.00K20K common stock

Board Justification

The vested stock represents shares that were granted in previous years and vested in 2023, paid out as common stock.

Performance Metrics

Performance metrics include revenue targets, operational efficiency, and overall company performance relative to peers.

C

Patrick J. McEnany

Ex-CEO of Catalyst Pharmaceutical

Education

Not specified

Sector of Economy

Healthcare

Born

September 12, 1944 - 81 years ago

CEO of Catalyst Pharmaceutical for

9 years 7 months (May 2014 - Dec 2023)

Previous Experience

Chairman and CEO of Catalyst Pharmaceuticals, Inc.

Holdings

Track Patrick J. McEnany's stock holdings and portfolio value over time.

Charitable Transactions

CPRX

50,100 shares

CPRX

Recent Charitable Transactions

CPRX

5,100 shares

CPRX

Aug 22, 2024

Charity

CPRX

45,000 shares

CPRX

Aug 15, 2024

Charity

Insider Trading

Patrick J. McEnany's recent stock transactions, purchases, and sales filed with the SEC.

CPRX

5,100 shares

CPRX

Aug 22, 2024

Charity

CPRX

45,000 shares

CPRX

Aug 15, 2024

Charity

Rivals

Compare Patrick J. McEnany with competitor CEOs and industry peers.